During a routine prenatal evaluation at 34 weeks gestation, a primigravid patient with a well-documented history of systemic lupus erythematosus reports new-onset swelling in her hands and face over the past week. Her blood pressure today is 152/96 mmHg, which is elevated from a baseline of 110/70 mmHg. Laboratory evaluation reveals a serum creatinine of 1.1 mg/dL (baseline 0.6 mg/dL) and a urine dipstick showing 3+ protein. The physician is attempting to determine whether these findings represent severe preeclampsia or an acute lupus nephritis flare. Which of the following laboratory findings would most specifically support a diagnosis of an active lupus flare in this patient?
- Decreased serum C3 and C4 levelsAnswer
- BDecreased hemoglobin concentration
- CElevated serum uric acid concentration
- DPresence of antinuclear antibodies
- EPresence of thrombocytopenia
Answer
Decreased serum C3 and C4 levels
The correct answer is decreased serum C3 and C4 levels. Differentiating between an acute lupus nephritis flare and severe preeclampsia is a common clinical challenge in pregnant patients with systemic lupus erythematosus (SLE) because both conditions present with new-onset hypertension, generalized edema, and proteinuria. The distinguishing factor lies in the pathophysiology: a lupus nephritis flare is driven by active immune complex deposition, which actively consumes complement proteins. Therefore, decreased levels of C3 and C4, often accompanied by rising anti-dsDNA titers, strongly point to an SLE flare. In contrast, preeclampsia does not involve complement consumption, and complement levels remain normal or even slightly elevated due to the physiologic acute-phase response of pregnancy.
Step-by-Step Solution
Key Concept
Differentiating lupus nephritis from preeclampsia during pregnancy relies on markers of SLE disease activity, specifically hypocomplementemia (decreased C3/C4) and increasing anti-dsDNA titers.
Estimated Time:1m 15s